This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Kangabio Co., Ltd. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovations of Diyuan Xue
Introduction
Diyuan Xue is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly through his innovative work on interleukin fusion proteins. His research has the potential to impact therapeutic methods in various medical applications.
Latest Patents
Diyuan Xue holds a patent for "HOMODIMERIC OR HETERODIMERIC INTERLEUKIN 12 FUSION PROTEINS, AND COMPOSITIONS AND THERAPEUTIC METHODS THEREOF." This patent showcases his expertise in developing novel therapeutic proteins that could enhance treatment options for various diseases.
Career Highlights
Xue is currently associated with Shanghai Kangabio Co., Ltd., where he continues to advance his research in biotechnology. His work has garnered attention for its innovative approach to protein engineering and therapeutic applications.
Collaborations
Diyuan Xue has collaborated with notable colleagues, including Yang-Xin Fu and Hua Peng. These partnerships have fostered a collaborative environment that enhances the research and development of new biotechnological solutions.
Conclusion
Diyuan Xue's contributions to the field of biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic methods and protein engineering.